Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

NovaBridge Biosciences (NBP) Debt to Equity (2018 - 2023)

NovaBridge Biosciences (NBP) has 4 years of Debt to Equity data on record, last reported at $0.02 in Q4 2023.

  • On a quarterly basis, Debt to Equity rose 167.77% to $0.02 in Q4 2023 year-over-year; TTM through Dec 2023 was $0.02, a 167.77% increase, with the full-year FY2023 number at $0.02, up 164.56% from a year prior.
  • Debt to Equity reached $0.02 in Q4 2023 per NBP's latest filing, up from $0.01 in the prior quarter.
  • Over the last five years, Debt to Equity for NBP hit a ceiling of $0.02 in Q4 2023 and a floor of -$0.02 in Q4 2019.
  • A 3-year average of $0.0 and a median of $0.01 in 2022 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: soared 70.66% in 2019, then skyrocketed 167.77% in 2023.
  • Tracing NBP's Debt to Equity over 3 years: stood at -$0.02 in 2019, then skyrocketed by 126.51% to $0.01 in 2022, then surged by 167.77% to $0.02 in 2023.
  • Business Quant data shows Debt to Equity for NBP at $0.02 in Q4 2023, $0.01 in Q2 2023, and $0.01 in Q4 2022.